Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akebia Therapeutics (AKBA) Change in Acquisitions & Divestments (2016 - 2021)

Akebia Therapeutics has reported Change in Acquisitions & Divestments over the past 6 years, most recently at $20.0 million for Q2 2021.

  • Quarterly Change in Acquisitions & Divestments changed N/A to $20.0 million in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $20.0 million through Mar 2022, down 75.0% year-over-year, with the annual reading at $40.0 million for FY2021, 33.6% down from the prior year.
  • Change in Acquisitions & Divestments was $20.0 million for Q2 2021 at Akebia Therapeutics, roughly flat from $20.0 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $117.8 million in Q2 2018 and troughed at -$109.8 million in Q3 2018.
  • The 5-year median for Change in Acquisitions & Divestments is $29.6 million (2017), against an average of $27.8 million.
  • Year-over-year, Change in Acquisitions & Divestments tumbled 350.98% in 2018 and then skyrocketed 8063.27% in 2021.
  • A 5-year view of Change in Acquisitions & Divestments shows it stood at $52.1 million in 2017, then plummeted by 310.63% to -$109.8 million in 2018, then soared by 120.49% to $22.5 million in 2019, then skyrocketed by 166.67% to $60.0 million in 2020, then crashed by 66.67% to $20.0 million in 2021.
  • Per Business Quant, the three most recent readings for AKBA's Change in Acquisitions & Divestments are $20.0 million (Q2 2021), $20.0 million (Q1 2021), and $60.0 million (Q4 2020).